Herbs (Global Traditional) · Middle Eastern
Pomegranate (Punica granatum) (Punica granatum)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Pomegranate (Punica granatum) contains high concentrations of ellagitannins and punicalagins that provide potent anti-inflammatory effects. These polyphenolic compounds reduce inflammatory markers like IL-6 and C-reactive protein by up to 32% in clinical studies.
Pomegranate (Punica granatum) is a fruit-bearing deciduous shrub native to the Middle East, widely cultivated in Mediterranean, Caucasus, northern India, and Southeast Asia regions. The fruit's arils, juice, peel, and seeds are extracted via cold-pressing for juice or solvent extraction/lyophilization for standardized polyphenolic extracts like POMx or PFE.
Clinical evidence includes a phase II RCT in prostate cancer patients showing increased urolithin A metabolites (PMID: 33095939), and meta-analyses confirming anti-inflammatory and antioxidant effects. Studies in hemodialysis patients (n=101), type 2 diabetes, and rheumatoid arthritis (n=55) demonstrate consistent reductions in inflammatory biomarkers, with a recent IBD study (PMID: 40255128) showing gene expression modulation.
Clinically studied dosages include: Juice 100-300 mL/day (250 mL/day for diabetes, 100 mL 3x/week for hemodialysis); Standardized extracts (POMx/PFE) 500-1000 mg/day of polyphenols (equivalent to 8 oz juice); Treatment duration ranges from 8 weeks to 18 months depending on condition. Consult a healthcare provider before starting any new supplement.
Pomegranate's ellagitannins and punicalagins are metabolized by gut bacteria into urolithins, which inhibit NF-κB signaling pathways and reduce pro-inflammatory cytokine production. These compounds also activate Nrf2 pathways, enhancing endogenous antioxidant enzyme expression including superoxide dismutase and catalase. The anthocyanins delphinidin and cyanidin improve endothelial function by increasing nitric oxide bioavailability.
Multiple randomized controlled trials demonstrate pomegranate's anti-inflammatory effects, with studies showing 12-32% reductions in IL-6 and hs-CRP levels in participants consuming 200-500mg daily for 8-12 weeks. A meta-analysis of 8 RCTs on cardiovascular outcomes showed mixed results for blood pressure reduction, with some studies reporting 5-12 mmHg systolic pressure decreases. Antioxidant studies consistently show improved ORAC scores and reduced lipid peroxidation markers. Most trials used standardized extracts containing 40% ellagic acid with sample sizes ranging from 48-100 participants.
Pomegranate is generally well-tolerated with mild gastrointestinal upset reported in less than 5% of users at standard doses. It may interact with warfarin and other anticoagulants due to its vitamin K content and potential effects on CYP2C9 enzymes. Individuals with tree fruit allergies should exercise caution as cross-reactivity has been reported. Pregnancy and breastfeeding safety data is limited, though dietary amounts are considered safe.
